Nava Therapeutics Management Team | Org Chart - RocketReach Nava Therapeutics employs 10 employees The Nava Therapeutics management team includes Kalina Paunovska (Co-Founder), Curtis Dobrowolski (Co-Founder), and Ritika Dwivedi (Associate Director)
Discover SENT-Seq its Impact on LNPs - Echelon Biosciences In this webinar, Dr Kalina Paunovska, co-founder of Nava Therapeutics, shared how her team is using single cell RNA sequencing (SENT-seq) to accelerate the discovery of promising new LNP candidates https: www nature com articles s41565-022-01146-9
Drug delivery systems for RNA therapeutics - Nature RNA therapies can manipulate gene expression or produce therapeutic proteins, making these drugs suitable for pathologies with established genetic targets, including infectious diseases, cancers,
Echelon Biosciences Using single cell RNA sequencing to identify novel lipid nanoparticle candidates with Dr Kalina Paunovska, co-founder of Nava Therapeutics
Kalina Paunovska email address phone number | Nava Therapeutics Co . . . Kalina Paunovska, based in Atlanta, GA, US, is currently a Co-Founder at Nava Therapeutics, bringing experience from previous roles at Georgia Institute of Technology, Solid Biosciences and University of Miami, Miller School of Medicine